Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record history now includes the added 'Revision: v3.7.0' and the removed 'Revision: v3.6.6'. This indicates the record has been updated to a newer version.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the study's record history, signaling a recent sponsor update. The previous revision, v3.6.5, was removed from the visible history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe References section was removed from the study record page, eliminating the list of cited sources from the history view.SummaryDifference0.1%

- Check65 days agoChange DetectedThe revision label on the history page updated from v3.6.4 to v3.6.5, indicating a small update to the page's versioning. This does not modify study data or public content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now shows Revision: v3.6.4 as the current revision, replacing the previous v3.6.3.SummaryDifference0.1%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.